A respiratory gas analyzer for measuring the cardiac output of a subject includes a flow meter and an oxygen sensor interconnected with one another between a mouthpiece and a source of respiratory gases, which may be a controlled source or the atmosphere. An oximeter provides measurements of the oxygen saturation of the subject. A computer connected to receive the signals from the flow meter, oxygen sensor, and oximeter can then calculate the subject's cardiac output.

Patent
   6517496
Priority
May 10 1999
Filed
Nov 07 2000
Issued
Feb 11 2003
Expiry
May 10 2020
Assg.orig
Entity
Small
5
122
EXPIRED
13. A method for non-invasive cardiac output measurement of a subject, said method comprising the steps of:
(a) determining oxygen consumption of a subject;
(b) determining end-tidal oxygen concentration of the subject; and
(c) calculating the cardiac output of the subject based on the oxygen consumption and the end-tidal oxygen concentration determined in steps (a) and (b).
16. A method for non-invasive cardiac output measurement of a subject, said method comprising the steps of:
(a) determining oxygen consumption and arterial oxygen content of a subject over a first time interval and for a first oxygen concentration;
(b) changing the oxygen concentration breathed by the subject for a second time interval wherein the second time interval is less than the circulation time of the subject; and
(c) calculating the cardiac output of the subject based on the relative change in both oxygen consumption and arterial oxygen content determined in steps (a) and (b).
1. A respiratory gas analyzer for measuring cardiac output of a subject, said analyzer comprising:
a respiratory connector operative to be supported in contact with a subject so as to pass inhaled and exhaled gases as the subject breathes;
a flow sensor operatively connected to said respiratory connector adapted to generate electrical signals as a function of the volume of gases which pass therethrough;
an oxygen sensor for sensing the concentration of oxygen in the exhaled gases;
means for determining the concentration of oxygen in the inhaled gases and generating a signal representative of the oxygen consumed by the subject during each breath;
conduits interconnecting said respiratory connector, said flow meter, and said oxygen sensor;
an oximeter for enabling a determination to be made of the concentration of oxygen in the subject's arterial blood; and
a computer for receiving output signals from said flow sensor, said signal representative of the oxygen consumed by the subject during each breath, and said oximeter to calculate the cardiac output of the subject without the need for sensing the concentration of oxygen in the subject's venous blood.
2. The analyzer of claim 1, wherein, in a two-measurement procedure, said computer calculates the cardiac output (C.O.) of the subject according to the following equation: C . O . = Δ ⁢ ⁢ VO 2 Δ ⁢ ⁢ CaO 2
wherein: ΔVO2 is the difference in said consumed oxygen in the two-measurement procedure, and ΔCaO2 is the difference in said arterial oxygen in the two-measurement procedure;
and wherein: the two-measurement procedure involves:
(a) a first measurement of said consumed oxygen and said arterial oxygen during a first time interval, and
(b) a second measurement, following a change in the oxygen content of the inhaled air, during a second time interval having a duration less than the blood circulation time of the subject.
3. The analyzer of claim 2, wherein said computer calculates the cardiac output (C.O.) of the subject according to the following equation: C . O . = VO 2 CaO 2 - CvO 2
wherein: VO2 is the oxygen consumed during a breath; CaO2 is the concentration of oxygen in the subject's arterial blood; and CvO2 is the concentration of oxygen in the subject's venous blood, which is assumed to be the same as the end-tidal oxygen concentration in the exhaled air.
4. The analyzer of claim 1 further including a gas blender operatively connected in fluid communication with said conduits for changing the concentration of the oxygen in the inhaled gases.
5. The analyzer of claim 1, wherein said oxygen sensor is a fluorescence quench oxygen sensor.
6. The analyzer of claim 1, wherein said oxygen sensor is a side-port sampling oxygen sensor.
7. The analyzer of claim 1, wherein said respiratory connector is a mouthpiece.
8. The analyzer of claim 4, wherein said flow sensor, said oxygen sensor, said oximeter, and said gas blender comprise a mechanism for transferring output signals therefrom to said computer.
9. The analyzer of claim 8, wherein said mechanism comprises a conductive line.
10. The analyzer of claim 4, wherein said gas blender is operatively connected to a source of respiratory gas.
11. The analyzer of claim 10, wherein said source of respiratory gas is the atmosphere.
12. The analyzer of claim 10, wherein said source of respiratory gas is a source of oxygen.
14. The method of claim 13, wherein the cardiac output (C.O.) is calculated according to the following equation: C . O . = VO 2 CaO 2 - CvO 2
wherein: VO2 is the oxygen consumed during a breath; CaO2 is the concentration of oxygen in the subject's arterial blood; and CvO2 is the concentration of the oxygen in the subject's venous blood and is determined in accordance with the equation
CvO2=(SvO2)(Hbg)(1.36)+(0.0031)(PvO2)
wherein SvO2 is the oxygen saturation, Hbg is the hemoglobin concentration, and PvO2 is the dissolved venous plasma oxygen and is assumed to be the determined end-tidal oxygen concentration of the subject.
15. The method of claim 14, wherein arterial oxygen content is determined in accordance with the equation
CaO2=(SaO2)(Hbg)(1.36)+(PaO2)(0.0031)
wherein SaO2 is the arterial oxygen saturation, Hbg is the hemoglobin concentration, and PaO2 is the dissolved arterial oxygen concentration.
17. The method of claim 16, wherein the cardiac output (C.O.) of the subject is calculated according to the following equation: C . O . = Δ ⁢ ⁢ VO 2 Δ ⁢ ⁢ CaO 2
wherein ΔVO2 is said relative change in oxygen consumption and ΔCaO2 is said relative change in arterial oxygen.
18. The method of claim 16, wherein said first time interval ranges from approximately one to five minutes.
19. The method of claim 18, wherein said first time interval ranges from approximately two to three minutes.
20. The method of claim 16, wherein said second time interval ranges from approximately twenty seconds to sixty seconds.
21. The method of claim 20, wherein said second time interval ranges from approximately thirty seconds to fifty seconds.
22. The method of claim 16, wherein the oxygen concentration in step (b) is increased from approximately 40 percent to approximately 50 percent.

This application claims benefit of Ser. No. 60/133,685 filed May 10, 1999.

The present invention relates to measurement of cardiac output of a patient. More specifically, the present invention relates to an apparatus and method for non-invasive cardiac output measurement of a subject utilizing a respiratory gas analyzer employing a flow sensor, an oxygen sensor, and a pulse oximeter which are interconnected to measure the cardiac output of the subject.

U.S. Pat. No. 5,836,300 to Applicant discloses a respiratory gas analyzer for measuring the metabolic activity and the cardiac output of a subject including a bidirectional flow meter and a capnometer sensor interconnected by conduits and valving between a mouthpiece and a source of respiratory gases which can be a controlled source or the atmosphere. A computer receiving signals from the flow meter and the capnometer can then calculate the subject's metabolic activity. When valving is shifted, a portion of the exhaled gases are stored in the conduit so that upon inhalation, the subject inhales a substantial portion of rebreathed gases. The computer can then calculate the patient's cardiac output as a function of the changes in total carbon dioxide content of the exhaled gas before and after the valve is shifted from a direct input to a rebreathed position and the difference in end-tidal carbon dioxide between the two positions.

The cardiac output of a patient, that is the volume of blood ejected from the heart per unit time, is an important measured parameter in hospitalized patients. Currently, cardiac output is routinely measured by invasive techniques including thermal dilution using an indwelling pulmonary artery catheter. This technique has several disadvantages including the morbidity and mortality risks of placing an invasive intracardiac catheter, the infectious disease risks, significant expense and the fact that it provides an intermittent rather than a continuous measurement. A noninvasive, reusable cardiac output measurement device would substantially improve patient care and reduce hospital costs.

The partial rebreathing technique mentioned above is a known method for cardiac output measurement. As described in Kapec and Roy, "The Noninvasive Measurement of Cardiac Output Using Partial CO2 Rebreathing," IEEE Transactions on Biomedical Engineering, Vol. 35, No. 9, September 1988, pp. 653-659, the method utilizes well known Fick procedures, substituting carbon dioxide for oxygen, and employing a sufficiently short measurement period such that venous carbon dioxide levels and cardiac output can be assumed to remain substantially constant during the measurement.

U.S. Pat. No. 4,949,724 to Mahutte et al. discloses a method and apparatus for continuously monitoring cardiac output by utilizing a modified Fick equation. The Mahutte et al. patent replaces VO2 in the Fick equation by VCO2 divided by a constant representative of the gas exchange ratio of a patient in order to eliminate inaccuracies associated with monitoring the rate of uptake of oxygen.

In its original form, the Fick method of measuring cardiac output requires blood gas values for arterial and mixed venous blood as follows: C . O . = VO 2 CaO 2 - CvO 2

where C.O. is cardiac output, VO2 is oxygen consumption, CaO2 is the arterial oxygen content, and CvO2 is the venous oxygen content.

By utilizing a respiratory analyzer with a fast-response oxygen sensor, the cardiac output can be determined based on the end-tidal oxygen concentration (EtO2). End-tidal oxygen concentration is the lowest value of oxygen concentration in breath. The end-tidal oxygen concentration approximates the pulmonary capillary oxygen concentration.

Alternatively, at different points in time, it is also true that C . O . = VO 2 ⁢ ( 1 ) CaO 2 ⁢ ( 1 ) - CvO 2 ⁢ ( 1 ) = VO 2 ⁢ ( 2 ) CaO 2 ⁢ ( 2 ) - CvO 2 ⁢ ( 2 ) .

If the oxygen concentration of the inspired gas is temporarily increased or decreased, the change in alveolar oxygen concentration will cause a transient uptake or release of oxygen across the pulmonary capillaries, thereby resulting in a change in the measured VO2 and arterial oxygen content (CaO2). If these parameters are measured during an interval of time less than the circulation time (i.e., less than approximately thirty-fifty seconds), then the venous oxygen content (CvO2) level remains essentially constant during this period and can be removed from the equation. Therefore, cardiac output can be determined based on the equation C . O . = Δ ⁢ ⁢ VO 2 Δ ⁢ ⁢ CaO 2

The use of these novel concepts in combination with the apparatus and method of the present invention therefore allows for the non-invasive measurement of cardiac output utilizing measurements of airway gases and arterial oxygen concentrations, both of which can be done by non-invasive techniques.

The present invention is accordingly directed toward an airway-based respiratory gas analyzer for measuring the cardiac output of a subject. In a preferred embodiment of the analyzer of the present invention, the analyzer includes a respiratory connector operative to be supported in contact with a subject so as to pass inhaled and exhaled gases as the subject breathes. A flow meter operatively connected to the respiratory connector generates electrical signals as a function of the volume of gases which pass therethrough and, in combination with the signals generated by an oxygen sensor, allows for the determination of oxygen consumption (VO2) by integrating the flow and oxygen concentration signals over an entire breath. The oxygen sensor can also provide for the measurement of end-tidal (EtO2) concentration. An oximeter provides measurements of the subject's oxygen saturation. A computation unit receives the output signals from the flow sensor, oxygen sensor and oximeter and calculates the cardiac output based on the generated signals.

An alternative mechanism for performing measurements of the subject's cardiac output includes the subject placing the mouthpiece of the analyzer into their mouth and breathing a first oxygen concentration for a first period of time. Typically, the source of respiratory gases is atmospheric air. As the subject breathes, oxygen consumption (VO2) is determined as the integral of the flow and oxygen concentration signals over the entire breath. The oximeter provides a measurement of the subject's oxygen saturation which is utilized to calculate the subject's arterial oxygen content. After obtaining the measurement of the oxygen consumption (VO2) and arterial oxygen content (CaO2) over the first time period, the oxygen blender is caused to provide an increase or decrease in the airway oxygen concentration of the subject for a second period of time which is less than the subject's circulation time. The oxygen consumption (VO2) and arterial oxygen content (CaO2) are measured over this second time period on a breath-by-breath basis and are utilized in calculating the subject's cardiac output.

According to one aspect of the present invention, there is provided a respiratory gas analyzer for measuring cardiac output of a subject, said analyzer comprising:

a respiratory connector operative to be supported in contact with a subject so as to pass inhaled and exhaled gases as the subject breathes;

a flow sensor operatively connected to said respiratory connector adapted to generate electrical signals as a function of the volume of gases which pass therethrough;

an oxygen sensor for sensing the concentration of oxygen in the inhaled and exhaled gases, to thereby enable a determination to be made of the oxygen consumed by the subject during each breath;

conduits interconnecting said respiratory connector, said flow meter, and said oxygen sensor;

an oximeter for enabling a determination to be made of the concentration of oxygen in the subject's arterial blood; and

a computer for receiving output signals from said flow sensor, said oxygen sensor, and said oximeter to calculate the cardiac output of the subject without the need for sensing the concentration of oxygen in the subject's venous blood.

According to one preferred embodiment of the invention described below, the analyzer is used in a two-measurement procedure, wherein the computer calculates the cardiac output (C.O.) of the subject according to the following equation: C . O . = Δ ⁢ ⁢ VO 2 Δ ⁢ ⁢ CaO 2

wherein: ΔVO2 is the difference in said consumed oxygen in the two-measurement procedure, and ΔCaO2 is the difference in said arterial oxygen in the two-measurement procedure;

and wherein: the two-measurement procedure involves:

(a) a first measurement of said consumed oxygen and said arterial oxygen during a first time interval, and

(b) a second measurement, following a change in the oxygen content of the inhaled air, during a second time interval having a duration less than the blood circulation time of the subject.

According to a second described preferred embodiment, the computer calculates the cardiac output (C.O.) of the subject computer calculates the cardiac output (C.O.) of the subject according to the following equation: C . O . = VO 2 CaO 2 - CvO 2

wherein: VO2 is the oxygen consumed during a breath; CaO2 is the concentration of oxygen in the subject's arterial blood; and CvO2 is the concentration of oxygen in the subject's venous blood, which is assumed to be the same as the end-tidal oxygen concentration in the exhaled air.

Other features, advantages and applications of the present invention will be made apparent from the following detailed description of the preferred embodiments.

Other advantages and applications of the present invention will be made apparent by the following detailed description of preferred embodiments of the invention. The description makes reference to the accompanying drawings in which:

FIG. 1 is a schematic representation of a first embodiment of the present invention;

FIG. 2 is a schematic representation of a second embodiment of the present invention; and

FIG. 3 is a graph of oxygen concentration over time measured in milliseconds to illustrate oxygen concentration as recorded with a fast-response oxygen sensor and is also illustrative end-tidal oxygen concentration.

Referring to FIG. 1, a preferred embodiment of the present invention includes an airway-based cardiac output analyzer, generally indicated at 10, having a mouthpiece 12, a flow sensor 14, and a gas sensor 16. The flow sensor 14 and the gas sensor 16 are disposed in fluid communication with one another.

The mouthpiece 12 is adapted to engage the inner surfaces of a user's mouth, so as to form the sole passage for flowing respiratory gases into and out of the mouth. A nose clamp of conventional construction (not shown) can be employed in connection with the mouthpiece 12 to assure that all respiratory gas passes through the mouthpiece 12. In alternative configurations, a mask that engages the nose as well as the mouth of the user can be employed or an endotracheal tube could also be utilized.

The mouthpiece 12 is located adjacent to a bi-directional volume flow sensor 14. The flow sensor is preferably an ultrasonic flow meter such as an ultrasonic transit time flow meter such as that manufactured by NDD Medizintechnik AG, Zurich, Switzerland, and disclosed in U.S. Pat. Nos. 3,738,169; 4,425,805; 5,419,326; and 5,645,071. Preferably, the ultrasonic flow meter transmits and receives ultrasonic pulses along a path which is either parallel to or has a substantial component in the direction of the flow. The gas flow acts to advance or retard the flow of pulses so that the full transit time of the pulses is a function of the flow rate. Alternatively, the flow sensor 14 can be of the pressure differential type such as manufactured by Medical Graphics Corporation, St. Paul, Minn. under the trademark MEDGRAPHICS and of the general type illustrated in U.S. Pat. No. 5,038,773. Alternatively, other types of flow transducers such as pneumatics or spirometers could also be employed. The electrical output of the bi-directional flow sensor 14 is connected to a computation unit 20 through a conductive line 22.

The other end of the flow sensor 14 is connected to the gas sensor 16. The gas sensor 16 is preferably a fast-response (i.e. 50-80 millisecond response time), flow-through type oxygen sensor and is preferably of the fluorescent quench type as disclosed in U.S. Pat. Nos. 3,725,658; 5,517,313; and 5,632,958. The preferred embodiment can employ a sensor manufactured by Sensors for Medicine and Science, Inc., Germantown, Md. The electrical output of the gas sensor 16 is connected to the computation unit 20 through a conductive line 24. The computation unit 20 can include a source (not shown) for directing exciting radiation to a fluorescent coating disposed on the oxygen sensor 16 and sensing the resulting fluorescence intensity which is diminished as a function of the concentration of oxygen in the gas flowing over its surface to produce a direct measurement of oxygen concentration. The exciting radiation and fluorescent signal can be carried to the sensor 16 by an optical fiber (not shown).

A pulse oximeter 26 can be utilized to monitor oxygen saturation by pulse oximetry. The pulse oximeter 26 provides an output signal which is received by the computation unit 20 which is indicative of saturation percentage. The output signal of the pulse oximeter 26 is connected to the computational unit 20 through a conductive line 28. In a preferred embodiment, the pulse oximeter is preferably of the type manufactured by Datax-Ohlmeda, Louisville, Colo. Alternatively, for most healthy individuals, the pulse oximeter 26 can be omitted and the oxygen saturation can be assumed to be approximately 95-96%.

Utilizing the Fick equation, in combination with the airway-based respiratory gas analyzer 10 having the flow sensor 14 and the fast-response oxygen sensor 16, allows for the determination of a subject's cardiac output by utilizing measurements of end-tidal oxygen concentration and VO2. The airway-based gas analyzer 10 allows for the determination of end-tidal oxygen concentration (EtO2) as illustrated in FIG. 3. If one assumes that EtO2≈PvO2 (dissolved venous oxygen concentration in the plasma), then using the PvO2 and the hemoglobin concentration, the SvO2 can be determined based on the oxygen dissociation curve. The pulse oximeter 26 can be used to obtain oxygen saturation movement so that based on the Fick equation of C . O . = VO2 CaO 2 - CvO 2

wherein VO2 is measured by the airway based respiratory analyzer, CaO2 and CvO2 are determined according to the equations

CaO2=[(SaO2)(Hgb)(1.36)+(PaO2)(0.0031)] and

CvO2=[(SvO2)(Hgb)(1.36)+(PvO2)(0.0031)], respectively,

wherein SaO2 is the oxygen saturation measurement obtained by pulse oximetry, Hgb is the hemoglobin concentration (which is entered as a known value or by direct measurement), and PvO2 is obtained from the measurement of EtO2. It is assumed that EtO2 approximates PvO2 and, if the PvO2 and the hemoglobin concentrations are known, using the oxygen dissociation curve, SvO2 can be determined. The pulse oximeter 26 measures SaO2 (alternatively, SaO2 and PaO2 can be reasonably assumed).

Referring to FIG. 2, in an alternative embodiment of the present invention is shown wherein like numerals represent like elements among the embodiments, a gas blender 18 is disposed directly adjacent to and in fluid communication with the gas sensor 16. The gas blender 18 is also in fluid communication with the atmosphere or a source and sink of respiratory gases. The gas blender 18 can also be connected to a ventilator or source of calibrated or known gases such as an external oxygen tank 30. The gas blender 18 is preferably computer controlled and is in electrical communication with the computation unit 20 through a conductive line 32. That is, the computation unit 20 can transmit signals to the gas blender 18 in order to modify, mix, or change the composition of the inhaled air passing through the cardiac output analyzer 10 to the subject. In other words, the gas blender 18 can be caused to allow an increase/decrease in the concentration of airway oxygen for a given or predetermined period of tim e .

In a further alternative embodiment, the pulse oximeter 26 can be replaced by a synchronized, side-port sampling oxygen sensor as is well known in the art. That is, a portion or sample of the gases flowing through the analyzer is directed via a port to an oxygen sensor.

The analyzer 10 can also incorporate an artificial nose and/or a bacterial filter as described in Applicant's previous patents or can incorporate a temperature sensor which provides a signal to the computation unit 20 to adjust the measurements as a finction of breath and external air temperature.

In operation, in order to non-invasively obtain a measurement of the cardiac output of a subject, the subject attaches the pulse oximeter 22 to a suitable portion of their body such as a finger or earlobe, the subject then places the mouthpiece 12 into their mouth and the oxygen consumption (VO2) is determined as the integral of the flow of oxygen concentration signals over an entire breath. The arterial oxygen concentration is calculated according to the formula:

CaO2=(SaO2)(Hbg)(1.36)+(0.0031)(PaO2)

where SaO2 is the oxygen saturation measurement obtained by the pulse oximeter 22, Hbg is the hemoglobin concentration (which is entered as a known value or obtained by direct measurement), and PaO2 is the dissolved arterial oxygen concentration. After obtaining a stable measurement of VO2 and CaO2 over a first time period of approximately two to three minutes, the gas blender 18 is caused to increase/decrease the concentration of oxygen (preferably, at least a 10% change in FIO2, e.g., 40% increased to 50%) supplied to the subject for a second time period less than the subject's circulation time of approximately thirty to fifty seconds. VO2 and CaO2 are monitored on a breath-by-breath basis during this time period and the cardiac output is then determined. Accordingly, the method and apparatus of the present invention take advantage of the phenomenon that if the oxygen concentration of the inspired gas is temporarily increased or decreased, the change in alveolar oxygen concentration will cause a transient uptake or release of oxygen across the pulmonary capillaries thereby resulting in a change in the measured VO2 and arterial oxygen content (CaO2). If these parameters are measured during an interval less than the circulation time (i.e., less than approximately thirty to fifty seconds), then the venous oxygen content (CvO2) can be ignored and the cardiac output of the subject can be calculated based on the equation C . O . = Δ ⁢ ⁢ VO 2 Δ ⁢ ⁢ CaO 2

In view of the teaching presented herein, other modifications and variations of the present invention will readily be apparent to those of skill in the art. The discussion and description are illustrative of some embodiments of the present invention, but are not meant to be limitations on the practice thereof. It is the following claims, including all equivalents, which defines the scope of the invention.

Mault, James R.

Patent Priority Assignee Title
7135001, Mar 20 2001 RIC Investments, LLC Rebreathing methods including oscillating, substantially equal rebreathing and nonrebreathing periods
7225022, Mar 12 2003 SHAPE MEDICAL SYSTEMS, INC Method of optimizing patient outcome from cardiac resynchronization therapy
7344497, Mar 26 2003 Charlotte-Mecklenburg Hospital Non-invasive device and method for measuring the cardiac output of a patient
9439577, Mar 27 2012 The University of Vermont and State Agricultural College Non-invasive methods for determining cardiac output
9820656, Jul 08 2011 LifeQ Global Limited Personalized nutritional and wellness assistant
Patent Priority Assignee Title
2630798,
2826912,
2831348,
2838399,
2869357,
2911825,
2920012,
3213684,
3220255,
3250270,
3306283,
3523529,
3527205,
3681197,
3726270,
3797480,
3799149,
3814091,
3834375,
3895630,
3938551, Jan 17 1972 Anesthesia rebreathing apparatus
3962917, Jul 03 1974 Minato Medical Science Co., Ltd. Respirometer having thermosensitive elements on both sides of a hot wire
4003396, Aug 08 1972 Proportional control closed circuit gas admission system
4051847, Jan 17 1972 Anesthesia rebreathing apparatus
4078554, Sep 18 1975 Synthelabo Spirometric device
4186735, Apr 21 1977 ENVIROMENTAL TECHNOLOGIES GROUP, INC Breathing apparatus
4188946, Oct 07 1977 Controllable partial rebreathing anesthesia circuit and respiratory assist device
4197857, Apr 06 1978 JOHNSON & JOHNSON MEDICAL INC System for measurement of oxygen uptake and respiratory quotient
4200094, Apr 05 1977 Siemens Aktiengesellschaft Apparatus for warming and moistening a respiration gas
4211239, May 03 1978 UNIVERSITY OF UTAH RESEARCH FOUNDATION FOUNDATION Neonatal oxygen consumption monitor
4221224, Jun 29 1978 Intermountain Health Care; Primary Children's Medical Center Non-airtight pulmonary measuring device
4230108, Mar 13 1979 Apparatus and method for sealing esophageal entrance to trachea above and below
4341867, Apr 21 1980 De Forende Bryggerier A/S Process for recovering enzymes from blood
4359057, Sep 30 1980 Apparatus for measuring oxygen consumption and the exchange of other breathing gases
4368740, Nov 03 1980 SensorMedics Corporation Physiologic analyzer
4386604, Feb 27 1981 Determination of the basal metabolic rate of humans with a whole-body calorimeter
4425805, Oct 31 1980 Tokyo Shibaura Denki Kabushiki Kaisha Respiration flowmeter
4440177, Jul 03 1980 Medical Graphics Corporation Respiratory analyzer system
4444201, Aug 27 1980 Tokyo Shibaura Denki Kabushiki Kaisha Respiration monitoring apparatus and method
4463764, Sep 29 1981 NORWEST BANK MINNESOTA, NATIONAL ASSOCIATION Cardiopulmonary exercise system
4572208, Jun 29 1983 Utah Medical Products, Inc. Metabolic gas monitoring apparatus and method
4598700, Mar 14 1983 Apparatus for measuring pulse rate and pulmonary volume
4608995, Jan 19 1983 Karolinska Institutet Institutionen for Medicinsk Teknik Method and apparatus for the non-invasive determination of the minute volume of the heart
4619269, Jun 29 1983 UTAH MEDICAL PRODUCTS, INC Apparatus and method for monitoring respiratory gas
4648396, May 03 1985 BRIGHAM AND WOMEN S HOSPITAL Respiration detector
4658832, Apr 01 1985 COSMED S R L Portable device for the survey of the breathing ventilation and of the oxygen consumption, connected by means of radio signals to a fixed reception and elaboration station
4753245, Mar 26 1985 ICOR AB Apparatus for measuring the oxygen uptake of a person
4756670, Oct 17 1986 NEW A C , INC ; A C INC Detecting method and apparatus using heat sensitive devices
4781184, Jan 13 1984 Closed circuit breathing apparatus and method of using same
4796639, Nov 05 1987 NORWEST BANK MINNESOTA, NATIONAL ASSOCIATION Pulmonary diagnostic system
4850371, Jun 13 1988 Novel endotracheal tube and mass spectrometer
4856531, Nov 04 1985 Instrumentarium Corp. Measuring device for metabolic quantities connectable to a respirator
4909259, Apr 21 1989 Method and apparatus for determining metabolic rate ratio
4914959, Apr 24 1987 DEN NORSKE STATS OLJESELSKAP A S Ultrasonic flow meter using obliquely directed transducers
4917108, Jun 29 1988 HEALTHETECH, INC Oxygen consumption meter
4949724, Dec 23 1988 Method and apparatus for continuous measurement of cardiac output
4955946, Dec 11 1986 Marquette Gas Analysis Respiratory CO2 detector circuit with high quality waveform
4986268, Apr 06 1988 Method and apparatus for controlling an artificial respirator
4998018, Mar 01 1989 NIHON KOHDEN CORPORATION Two-wavelength type respiratory gas concentration measuring apparatus
5022406, Oct 07 1986 Module for determining diffusing capacity of the lungs for carbon monoxide and method
5038773, Jun 08 1990 NORWEST BANK MINNESOTA, NATIONAL ASSOCIATION Flow meter system
5038792, Jun 29 1988 HEALTHETECH, INC Oxygen consumption meter
5042500, Jun 18 1990 NORWEST BANK MINNESOTA, NATIONAL ASSOCIATION Drying sample line
5042501, May 01 1990 Battelle Memorial Institute Apparatus and method for analysis of expired breath
5060506, Oct 23 1989 RIC Investments, LLC Method and apparatus for monitoring the content of binary gas mixtures
5060655, Nov 15 1988 Hans Rudolph, Inc. Pneumotach
5060656, May 22 1990 AeroSport, Inc. Metabolic rate analyzer
5069220, May 26 1989 BEAR MEDICAL SYSTEMS INC Measurement of gas concentration in exhaled breath
5072737, Apr 12 1989 Puritan-Bennett Corporation Method and apparatus for metabolic monitoring
5081871, Feb 02 1989 The United States of America as represented by the Secretary of the Breath sampler
5095900, Jan 22 1991 Mine Safety Appliances Company Respiration monitor
5095913, Sep 01 1989 DOLPHIN MEDICAL, INC , A CORPORATION OF CALIFORNIA Shutterless optically stabilized capnograph
5117674, May 22 1990 AeroSport, Inc. Metabolic rate analyzer
5119825, Feb 25 1991 NORWEST BANK MINNESOTA, NATIONAL ASSOCIATION Multi-functional patient valve
5178155, Jun 29 1988 MICROLIFE MEDICAL HOME SOLUTIONS INC Respiratory calorimeter with bidirectional flow monitors for calculating of oxygen consumption and carbon dioxide production
5179958, Jun 29 1988 MICROLIFE MEDICAL HOME SOLUTIONS INC Respiratory calorimeter with bidirectional flow monitor
5214966, Oct 31 1988 D-Flow Group AB Method and apparatus for measuring mass flow
5233996, May 20 1988 Datex-Ohmeda, Inc Patient interfacing system and method to prevent water contamination
5282473, Nov 10 1992 Spacelabs Healthcare LLC Sidestream infrared gas analyzer requiring small sample volumes
5285794, Dec 14 1992 Temple University of the Commonwealth System of Higher Education Respiratory gas monitor
5293875, Jun 16 1992 Silicon Valley Bank In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods
5299579, Nov 24 1989 MINCO AB Apparatus for examining a patient's pulmonary function
5303712, Jan 25 1993 NORWEST BANK MINNESOTA, NATIONAL ASSOCIATION Calibration method for single-breath carbon monoxide lung diffusing capacity test system
5309921, Feb 11 1992 SPECTRUM MEDICAL TECHNOLOGIES A GENERAL PARTNERSHIP OF TN; SPECTRUM TECHNOLOGY, INC , A CORP OF TN Apparatus and method for respiratory monitoring
5326973, Jan 03 1992 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO , LTD Device for gas analysis
5355879, Sep 28 1992 TELEFLEX LIFE SCIENCES PTE LTD Laryngeal-mask construction
5355893, Apr 06 1992 Vital signs monitor
5357972, May 17 1993 NORWEST BANK MINNESOTA, NATIONAL ASSOCIATION Disposable pneumotachograph flowmeter
5363857, May 22 1990 AeroSport, Inc. Metabolic analyzer
5398695, Mar 24 1994 NORWEST BANK MINNESOTA, NATIONAL ASSOCIATION Cardiopulmonary performance analyzer having dynamic transit time compensation
5402796, Sep 19 1990 University of Melbourne Arterial CO2 Monitor and closed loop controller
5419326, Jun 03 1992 ndd Medizintechnik AG Spirometer, more particularly an ultrasonic spirometer
5425374, Jun 03 1992 UEDA, HIDEO; Kabushiki Kaisha Kyoto Daiichi Kagaku Device and method for expiratory air examination
5450193, Feb 24 1992 Agilent Technologies Inc Raman spectroscopy of airway gases
5468961, Oct 08 1991 Fisher & Paykel Healthcare Limited Infrared gas analyser and humidity sensor
5503151, Sep 30 1993 ndd Medizintechnik AG Apparatus for measuring the parameters of respiratory gases
5570697, Jul 15 1994 OPTICAL COMMUNICATION PRODUCTS, INC Sensor for analyzing molecular species
5632281, Feb 06 1995 RIC Investments, LLC Non-invasive estimation of arterial blood gases
5645071, Jun 04 1993 ndd Medizintechnik AG Method for the measurement of the molar mass of gases or gas mixtures and an apparatus for the performance of the method
5647370, Jul 01 1994 ndd Medizintechnik AG Ultrasonic spirometer
5676132, Dec 05 1995 Pulmonary Interface, Inc. Pulmonary interface system
5705735, Aug 09 1996 Medical Graphics Corporation Breath by breath nutritional requirements analyzing system
5754288, Aug 09 1995 Kyoto Dai-Ichi Kagaku Co., Ltd. Optical measuring method of expiration components
5789660, Jul 15 1996 RIC Investments, LLC Multiple function airway adapter
5796009, Oct 24 1994 D-Flow Group AB Method for measuring in a fluid with the aid of sing-around technique
5800360, Feb 11 1992 SPECTRUM MEDICAL TECHNOLOGIES, INC Apparatus and method for respiratory monitoring
5816246, Sep 15 1994 Electronic pocket spirometer
5831175, Jun 12 1996 Welch Allyn, Inc. Method and apparatus for correcting temperature variations in ultrasonic flowmeters
5834626, Nov 29 1996 Colorimetric indicators for breath, air, gas and vapor analyses and method of manufacture
5836300, Mar 11 1996 MICROLIFE MEDICAL HOME SOLUTIONS INC Metabolic gas exchange and noninvasive cardiac output monitor
5922610, Jul 06 1993 Aerocrine AB System to be used for the determination of no levels in exhaled air and diagnostic methods for disorders related to abnormal no levels
5932812, May 22 1995 D-Flow Group AB Method and devices use in flow measurement
5957858, Jul 26 1996 POLESTAR TECHNOLOGIES, INC Systems and methods for monitoring relative concentrations of different isotopic forms of a chemical species
6010459, Apr 09 1996 Circassia AB Method and apparatus for the measurement of components of exhaled breath in humans
6044843, May 28 1997 Nellcor Puritan Bennett Incorporated Moisture resistant airway adapter for monitoring constituent gases
6162180, Dec 28 1998 Medtronic, Inc. Non-invasive cardiac monitoring system and method with communications interface
6309360, Mar 17 1997 MICROLIFE MEDICAL HOME SOLUTIONS INC Respiratory calorimeter
DE19810476,
EP459647,
EP712638,
GB2323292,
WO9640340,
////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Nov 07 2000Healthetech, Inc.(assignment on the face of the patent)
May 22 2002MAULT, JAMES R HEALTHETECH, INC ASSIGNMENT AGREEMENT0131280334 pdf
Aug 07 2006HEALTHETECH, INC Microlife CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0183380117 pdf
Apr 20 2009Microlife CorporationMICROLIFE MEDICAL HOME SOLUTIONS INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0227640520 pdf
Date Maintenance Fee Events
Jul 15 2003LTOS: Pat Holder Claims Small Entity Status.
Jul 28 2006M2551: Payment of Maintenance Fee, 4th Yr, Small Entity.
Sep 20 2010REM: Maintenance Fee Reminder Mailed.
Feb 10 2011M2552: Payment of Maintenance Fee, 8th Yr, Small Entity.
Feb 10 2011M2555: 7.5 yr surcharge - late pmt w/in 6 mo, Small Entity.
Apr 05 2011ASPN: Payor Number Assigned.
Sep 19 2014REM: Maintenance Fee Reminder Mailed.
Feb 11 2015EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Feb 11 20064 years fee payment window open
Aug 11 20066 months grace period start (w surcharge)
Feb 11 2007patent expiry (for year 4)
Feb 11 20092 years to revive unintentionally abandoned end. (for year 4)
Feb 11 20108 years fee payment window open
Aug 11 20106 months grace period start (w surcharge)
Feb 11 2011patent expiry (for year 8)
Feb 11 20132 years to revive unintentionally abandoned end. (for year 8)
Feb 11 201412 years fee payment window open
Aug 11 20146 months grace period start (w surcharge)
Feb 11 2015patent expiry (for year 12)
Feb 11 20172 years to revive unintentionally abandoned end. (for year 12)